{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:31Z","timestamp":1759333591188},"reference-count":28,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9780387317830"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-387-33026-7_4","type":"book-chapter","created":{"date-parts":[[2006,10,29]],"date-time":"2006-10-29T18:27:21Z","timestamp":1162146441000},"page":"35-44","source":"Crossref","is-referenced-by-count":4,"title":["Viral Haemorrhagic Fevers Caused by Lassa, Ebola and Marburg Viruses"],"prefix":"10.1007","author":[{"given":"Nigel","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","unstructured":"Advisory Committee on Dangerous Pathogens. (1996). Management and control of viral haemorrhagic fevers. http:\/\/www.hpa.org.uk\/infections\/topics_az\/VHF\/ACDP_VHF_guidance.pdf."},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nm0705-720","volume":"11","author":"S. Baize","year":"2005","unstructured":"Baize, S. (2005). A single shot against Ebola and Marburg virus. Nat Med 11:720\u20131.","journal-title":"Nat Med"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00001432-200110000-00003","volume":"14","author":"S. Baize","year":"2001","unstructured":"Baize, S., Marianneau, P., Georges-Courbot, M.C. and Deubel, V. (2001). Recent advances in vaccines against viral haemorrhagic fevers. Curr Opin Infect Dis 14:513\u20138.","journal-title":"Curr Opin Infect Dis"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","volume":"287","author":"L. Borio","year":"2002","unstructured":"Borio, L., Inglesby, T., Peters, C.J., Schmaljohn, A.L., Hughes, J.M., Jahrling, P.B., Ksiazek, T., Johnson, K.M., Meyerhoff, A., O\u2019toole, T., Ascher, M.S., Bartlett, J., Breman, J.G., Eitzen, E.M., Jr., Hamburg, M., Hauer, J., Henderson, D.A., Johnson, R.T., Kwik, G., Layton, M., Lillibridge, S., Nabel, G.J., Osterholm, M.T., Perl, T.M., Russell, P. and Tonat, K. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. Jama 287:2391\u2013405.","journal-title":"Jama"},{"key":"4_CR5","unstructured":"Centers for Disease Control and Prevention (2005a). http:\/\/www.bt.cdc.gov\/agent\/vhf\/index.asp."},{"key":"4_CR6","unstructured":"Centers for Disease Control and Prevention (2005b). http:\/\/www.cdc.gov\/ncidod\/dvrd\/spb\/mnpages\/dispages\/vhf.htm."},{"key":"4_CR7","unstructured":"Centers for Disease Control and Prevention (2005c). http:\/\/www.cdc.gov\/ncidod\/dvrd\/spb\/mnpages\/vhfmanual.htm."},{"key":"4_CR8","unstructured":"Eurosurveillance (2002). http:\/\/www.eurosurveillance.org\/em\/v07n03\/v07n03.pdf."},{"key":"4_CR9","unstructured":"Eurosurveillance (2004). http:\/\/www.eurosurveillance.org\/em\/v09n12\/0912-235.pdf."},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nri1154","volume":"3","author":"H. Feldmann","year":"2003","unstructured":"Feldmann, H., Jones, S., Klenk, H.D. and Schnittler, H.J. (2003). Ebola virus: from discovery to vaccine. Nat Rev Immunol 3:677\u201385.","journal-title":"Nat Rev Immunol"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/14760584.3.2.189","volume":"3","author":"S.P. Fisher-Hoch","year":"2004","unstructured":"Fisher-Hoch, S.P. and Mccormick, J.B. (2004). Lassa fever vaccine. Expert Rev Vaccines 3:189\u201397.","journal-title":"Expert Rev Vaccines"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399404008300","volume":"6","author":"T.W. Geisbert","year":"2004","unstructured":"Geisbert, T.W. and Hensley, L.E. (2004). Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 6:1\u201324.","journal-title":"Expert Rev Mol Med"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/nm1142","volume":"10","author":"T.W. Geisbert","year":"2004","unstructured":"Geisbert, T.W. and Jahrling, P.B. (2004). Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110\u201321.","journal-title":"Nat Med"},{"key":"4_CR14","unstructured":"Health Protection Agency (2005a). http:\/\/www.hpa.org.uk\/infections\/topics_az\/deliberate_release\/VHF\/homepage.asp."},{"key":"4_CR15","unstructured":"Health Protection Agency (2005b). http:\/\/www.hpa.org.uk\/infections\/topics_az\/VHF\/menu.htm."},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"S.M. Jones","year":"2005","unstructured":"Jones, S.M., Feldmann, H., Stroher, U., Geisbert, J.B., Fernando, L., Grolla, A., Klenk, H.D., Sullivan, N.J., Volchkov, V.E., Fritz, E.A., Daddario, K.M., Hensley, L.E., Jahrling, P.B. and Geisbert, T.W. (2005). Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786\u201390.","journal-title":"Nat Med"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/CMR.14.2.364-381.2001","volume":"14","author":"W.F. Klietmann","year":"2001","unstructured":"Klietmann, W.F. and Ruoff, K.L. (2001). Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev 14:364\u201381.","journal-title":"Clin Microbiol Rev"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.emc.2004.05.005","volume":"22","author":"R. Lowenstein","year":"2004","unstructured":"Lowenstein, R. (2004). Deadly viral syndrome mimics. Emerg Med Clin North Am 22:1051\u201365, ix\u2013x.","journal-title":"Emerg Med Clin North Am"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","volume":"4","author":"S. Mahanty","year":"2004","unstructured":"Mahanty, S. and Bray, M. (2004). Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4:487\u201398.","journal-title":"Lancet Infect Dis"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","volume":"155","author":"J.B. Mccormick","year":"1987","unstructured":"Mccormick, J.B., King, I.J., Webb, P.A., Johnson, K.M., O\u2019sullivan, R., Smith, E.S., Trippel, S. and Tong, T.C. (1987). A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445\u201355.","journal-title":"J Infect Dis"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"J.B. Mccormick","year":"1986","unstructured":"Mccormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., Elliott, L.H. and Belmont-Williams, R. (1986). Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20\u20136.","journal-title":"N Engl J Med"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMp058115","volume":"352","author":"N. Ndayimirije","year":"2005","unstructured":"Ndayimirije, N. and Kindhauser, M.K. (2005). Marburg hemorrhagic fever in Angola-fighting fear and a lethal pathogen. N Engl J Med 352:2155\u20137.","journal-title":"N Engl J Med"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1056\/NEJMp058109","volume":"352","author":"C.J. Peters","year":"2005","unstructured":"Peters, C.J. (2005). Marburg and Ebola-arming ourselves against the deadly filoviruses. N Engl J Med 352:2571\u20133.","journal-title":"N Engl J Med"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"J.K. Richmond","year":"2003","unstructured":"Richmond, J.K. and Baglole, D.J. (2003). Lassa fever: epidemiology, clinical features, and social consequences. Bmj 327:1271\u20135.","journal-title":"Bmj"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.det.2004.03.003","volume":"22","author":"M.R. Salvaggio","year":"2004","unstructured":"Salvaggio, M.R. and Baddley, J.W. (2004). Other viral bioweapons: Ebola and Marburg hemorrhagic fever. Dermatol Clin 22:291\u2013302, vi.","journal-title":"Dermatol Clin"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/35046108","volume":"408","author":"N.J. Sullivan","year":"2000","unstructured":"Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. and Nabel, G.J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605\u20139.","journal-title":"Nature"},{"key":"4_CR27","unstructured":"World Health Organization (2005a). http:\/\/www.who.int\/csr\/disease\/en\/."},{"key":"4_CR28","unstructured":"World Health Organization (2005b). http:\/\/www.who.int\/topics\/haemorrhagic_fevers_viral\/en\/."}],"container-title":["Advances in Experimental Medicine and Biology","Hot Topics in Infection and Immunity in Children III"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-387-33026-7_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T05:18:05Z","timestamp":1619500685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-387-33026-7_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9780387317830"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/0-387-33026-7_4","relation":{},"subject":[]}}